These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16888319)

  • 1. Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol.
    Anuurad E; Rubin J; Lu G; Pearson TA; Holleran S; Ramakrishnan R; Berglund L
    J Lipid Res; 2006 Nov; 47(11):2475-81. PubMed ID: 16888319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated role of two apoliprotein E polymorphisms on apolipoprotein B levels and coronary artery disease in a biethnic population.
    Ozturk Z; Enkhmaa B; Shachter NS; Berglund L; Anuurad E
    Metab Syndr Relat Disord; 2010 Dec; 8(6):531-8. PubMed ID: 20715976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans.
    Larifla L; Armand C; Bangou J; Blanchet-Deverly A; Numeric P; Fonteau C; Michel CT; Ferdinand S; Bourrhis V; Vélayoudom-Céphise FL
    PLoS One; 2017; 12(7):e0181620. PubMed ID: 28727855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E polymorphism in Vietnamese children and its relationship to plasma lipid and lipoprotein levels.
    Nghiem NT; Ta TT; Ohmori R; Kuroki M; Nguyen VC; Nguyen TK; Kawakami M; Kondo K
    Metabolism; 2004 Dec; 53(12):1517-21. PubMed ID: 15562392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians.
    Cuchel M; Wolfe ML; deLemos AS; Rader DJ
    Atherosclerosis; 2002 Jul; 163(1):169-74. PubMed ID: 12048136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study.
    Anuurad E; Lu G; Rubin J; Pearson TA; Berglund L
    J Lipid Res; 2007 Mar; 48(3):693-8. PubMed ID: 17172560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population.
    Pablos-Méndez A; Mayeux R; Ngai C; Shea S; Berglund L
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3534-41. PubMed ID: 9437203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults. The CARDIA Study. Coronary Artery Risk Development in Young Adults.
    Howard BV; Gidding SS; Liu K
    Am J Epidemiol; 1998 Nov; 148(9):859-68. PubMed ID: 9801016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans.
    Anuurad E; Yamasaki M; Shachter N; Pearson TA; Berglund L
    J Lipid Res; 2009 Jul; 50(7):1472-8. PubMed ID: 19252179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.
    Paultre F; Pearson TA; Weil HF; Tuck CH; Myerson M; Rubin J; Francis CK; Marx HF; Philbin EF; Reed RG; Berglund L
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2619-24. PubMed ID: 11116062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E polymorphism and renal disease.
    Oda H; Yorioka N; Ueda C; Kushihata S; Yamakido M
    Kidney Int Suppl; 1999 Jul; 71():S25-7. PubMed ID: 10412731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
    Lehtinen S; Lehtimäki T; Sisto T; Salenius JP; Nikkilä M; Jokela H; Koivula T; Ebeling F; Ehnholm C
    Atherosclerosis; 1995 Apr; 114(1):83-91. PubMed ID: 7605379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia.
    Deiana L; Pes GM; Carru C; Errigo A; Pettinato S; Carcassi C; Baggio G; Contu L
    Eur J Clin Invest; 1998 Apr; 28(4):290-4. PubMed ID: 9615906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis.
    Natarajan P; Bis JC; Bielak LF; Cox AJ; Dörr M; Feitosa MF; Franceschini N; Guo X; Hwang SJ; Isaacs A; Jhun MA; Kavousi M; Li-Gao R; Lyytikäinen LP; Marioni RE; Schminke U; Stitziel NO; Tada H; van Setten J; Smith AV; Vojinovic D; Yanek LR; Yao J; Yerges-Armstrong LM; Amin N; Baber U; Borecki IB; Carr JJ; Chen YI; Cupples LA; de Jong PA; de Koning H; de Vos BD; Demirkan A; Fuster V; Franco OH; Goodarzi MO; Harris TB; Heckbert SR; Heiss G; Hoffmann U; Hofman A; Išgum I; Jukema JW; Kähönen M; Kardia SL; Kral BG; Launer LJ; Massaro J; Mehran R; Mitchell BD; Mosley TH; de Mutsert R; Newman AB; Nguyen KD; North KE; O'Connell JR; Oudkerk M; Pankow JS; Peloso GM; Post W; Province MA; Raffield LM; Raitakari OT; Reilly DF; Rivadeneira F; Rosendaal F; Sartori S; Taylor KD; Teumer A; Trompet S; Turner ST; Uitterlinden AG; Vaidya D; van der Lugt A; Völker U; Wardlaw JM; Wassel CL; Weiss S; Wojczynski MK; Becker DM; Becker LC; Boerwinkle E; Bowden DW; Deary IJ; Dehghan A; Felix SB; Gudnason V; Lehtimäki T; Mathias R; Mook-Kanamori DO; Psaty BM; Rader DJ; Rotter JI; Wilson JG; van Duijn CM; Völzke H; Kathiresan S; Peyser PA; O'Donnell CJ;
    Circ Cardiovasc Genet; 2016 Dec; 9(6):511-520. PubMed ID: 27872105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative effects of the apolipoprotein E polymorphism in a biracial sample of 9-10-year-old girls.
    Sanghera DK; Ferrell RE; Aston CE; McAllister AE; Kamboh MI; Kimm SY
    Atherosclerosis; 1996 Sep; 126(1):35-42. PubMed ID: 8879432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E polymorphism in Omani dyslipidemic patients with and without coronary artery disease.
    Al-Yahyaee SA; Ganguly SS; Al Kindi MN; Al-Bahrani AI
    Hum Biol; 2007 Feb; 79(1):93-102. PubMed ID: 17985658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.
    Gungor Z; Anuurad E; Enkhmaa B; Zhang W; Kim K; Berglund L
    Atherosclerosis; 2012 Jul; 223(1):230-4. PubMed ID: 22632920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians.
    Anuurad E; Tracy RP; Pearson TA; Kim K; Berglund L
    Atherosclerosis; 2009 Jul; 205(1):290-5. PubMed ID: 19135196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population.
    Afroze D; Yousuf A; Tramboo NA; Shah ZA; Ahmad A
    Clin Exp Med; 2016 Nov; 16(4):551-556. PubMed ID: 26409839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.